NOVO NORDISK started the consumer program directly to consumers last week and sold WEGOVY at prices for those who did not have insurance or insurance without insurance.
The Novocare program allows the patient to buy a monthly Wegovy supply for $ 499. All capacity strengths from 0.25 milligrams to 2.4 milligrams are the same. Wegovy’s list price is about $ 1,350 a month.
Novo Nordisk says 90%of US patients taking Wegovy have $ 0 to $ 25 cofpe a month. The new program tries to lower the cost of people who do not cover the cost of obesity. But people in Medicare or Medicaid are inappropriate for the program.
Novocare also provides home delivery and refill notifications for WEGOVY prescriptions.
This initiative comes after the Food and Drug Administration (FDA) removes Wegovy from the list of drug shortages at the end of February. If there is a lack of drugs, the complex pharmacy can legally create a brand off -branded drug. Insurance does not cover the cost of complex drugs because it is not approved by the FDA.
“Novocare Pharmacy provides patients with access to authentic FDA WEGOVY, helping to avoid the serious risks that Compounding Marketplace can raise as respected by respected organizations, medical community experts and FDA.”
“If you use FDA approval drugs such as Wegovy, you can be clear and confident if you know that the drug used by medical professionals and patients has undergone strict reviews on safety, effects and quality.”
In recent years, remote healthy companies have emerged to provide cheap brand obesity pharmaceuticals. Companies such as HIMS & HERS and RO have partnered relationships with a composite pharmacy with national licenses and offer semi -grated and tira disciples who do not have brands as part of the cost of brand versions. However, some companies and non -regulated pharmacies have sold versions of these drugs, not FDA or national regulations.
The price of a composite semagluide through a remote health provider is $ 130 ~ $ 300 a month.
The FDA set up the deadline on April 22 to convert the traditional complex pharmacy to the brand’s drug or alternative on April 22.
ELI Lilly expands a similar program called LillyDirect to reduce the price of Zepbound, an obese drug for those who do not have insurance coverage. Lilly provides a single dose vial that the patient manages the self -management using needle and syringe. The price varies depending on the dose and the highest length vials are not available through the program.
Lillydirect also provides tele health counseling so that the patient can virtually meet with the provider. This offering raised concerns about over -expression.
~ Inside statement The American College of Physicians, published last year, emphasized the importance of “established and valid patient-doctor relationship” for high quality treatment.
“These direct consumer services have the potential for patients to leave the drug confusing and wrong information about the drug. Efforts to remove treatment barriers are important, but we should not devalue the proven benefits of patient-doctor’s relationship, ”ACP said.
Patients using Novocare can access the case manager to answer questions about Wegovy, but Novo Nordisk does not provide remote health services for providing prescriptions.
This is what it means to you
Novo Nordisk’s new Novocare program provides a patient who doesn’t have insurance and does not have insurance, providing access to Wegovy for $ 499 per month, much lower than the list price.
:max_bytes(150000):strip_icc()/grad111-b39b11256df2462c8b04851148a78e31.jpg)
